meta|COVID-19
  • Dynamic meta-analysis of evidences about drug efficacy and safety
  • adjuvant therapies
  • anti-inflammatoty and immuno-therapy
  • antiviral and associated therapy
  • control
  • miscellaneous
  • acetylcysteine
  • alpha lipoic acid
  • aviptadil
  • bevacizumab
  • bismuth
  • BLD-2660 (calpain inhibitor)
  • calcium channel blocker
  • camostat mesilate
  • continuous positive airway pressure (CPAP)
  • cytokine adsorption
  • diammonium glycyrrhizinate
  • dipyridamol
  • DPP-4 inhibitor
  • enoxaparin
  • kinin-kallikrein inhibitors
  • levamisole
  • metformin
  • natural killer (NK) cells
  • nicotin
  • nitric oxide (gas Inhalation or releasing solution)
  • ozonated autohemotherapy
  • pamrevlumab
  • povidone-iodine
  • proton pump inhibitors
  • PUL-042 inhalation solution
  • selinexor
  • statins
  • stem cells
  • tradipitant
  • tranilast
  • COVID-19
  • COVID 19 hospitalized
  • COVID 19 all comers
  • COVID-19 mild to moderate
  • COVID-19 severe or critically
  • COVID 19 outpatients
  • COVID-19 prophylaxis
  • infections other than COVID-19
  • preventing respiratory virus transmission